Financhill
Sell
19

ADTX Quote, Financials, Valuation and Earnings

Last price:
$10.75
Seasonality move :
-42.72%
Day range:
$10.35 - $12.92
52-week range:
$4.11 - $54,500.00
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
0.03x
P/B ratio:
2.34x
Volume:
17.2M
Avg. volume:
5.8M
1-year change:
-99.97%
Market cap:
$11M
Revenue:
$645.2K
EPS (TTM):
-$5,313.28

Analysts' Opinion

  • Consensus Rating
    No consensus rating exists at this time due to lack of analyst coverage.
  • Price Target Upside
    No price target exists because of limited analyst coverage.
  • Price Target Downside
    Similarly, at this time, analysts have not provided a price target so downside risk can't be assessed accurately at this time.

Fair Value

  • According to the consensus of 0 analysts, Aditxt has 5706167.54% upside to fair value with a price target of -- per share.

ADTX vs. S&P 500

  • Over the past 5 trading days, Aditxt has overperformed the S&P 500 by 27.48% suggesting its relative strength compared to the major market average is strong at this time.

Share Buyback

  • Aditxt does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.

Revenue Growth

  • Aditxt revenues have been falling on a year-over-year basis for 5 quarters in a row. In the most recent quarter Aditxt reported revenues of $6.9K.

Earnings Growth

  • Aditxt has grown year-over-year earnings for 0 quarters straight. In the most recent quarter Aditxt reported earnings per share of -$4,442.80.
Enterprise value:
19.3M
EV / Invested capital:
--
Price / LTM sales:
0.03x
EV / EBIT:
--
EV / Revenue:
90.85x
PEG ratio (5yr expected):
--
EV / Free cash flow:
-1.38x
Price / Operating cash flow:
--
Enterprise value / EBITDA:
--
Gross Profit (TTM):
-$630.2K
Return On Assets:
-144.57%
Net Income Margin (TTM):
-18947.07%
Return On Equity:
-620.2%
Return On Invested Capital:
-271.02%
Operating Margin:
-68588.24%
Trailing 12 Months Fiscal Quarters
Period Ending 2022-09-30 2023-09-30 2024-09-30 2023-09-30 2024-09-30
Income Statement
Revenue $853.2K $749.5K $212.1K $124.5K $6.9K
Gross Profit $178.6K $108.3K -$630.2K $17.6K -$460.7K
Operating Income -$26.8M -$25.8M -$30.2M -$8.1M -$4.7M
EBITDA -$40.7M -$25.7M -$29.7M -$8M -$4.6M
Diluted EPS -$18,820,568.72 -$1,951,299.01 -$217,609.45 -$275,363.08 -$6,045.89
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Balance Sheet
Current Assets $14.3M $12.4M $12.6M $3.4M $2.1M
Total Assets $15.4M $19.6M $19.2M $8.2M $29.8M
Current Liabilities $755.8K $3.6M $4.4M $11.2M $24.4M
Total Liabilities $1.6M $6.6M $6.5M $12.4M $25.4M
Total Equity $13.7M $13M $12.7M -$4.2M $4.4M
Total Debt -- -- $326.7K $4M $8.8M
Trailing 12 Months Fiscal Quarters
Period Ending 2022-09-30 2023-09-30 2024-09-30 2023-09-30 2024-09-30
Cash Flow Statement
Cash Flow Operations -$24.4M -$22M -$13.9M -$8M -$2.4M
Cash From Investing -$8.9M $165.3K -$2.3M -$9.4K -$1.3M
Cash From Financing $37M $14.2M $14.9M $9.6M $3.9M
Free Cash Flow -$24.8M -$22.1M -$13.9M -$8M -$2.4M
ADTX
Sector
Market Cap
$11M
$37.4M
Price % of 52-Week High
0.02%
45.61%
Dividend Yield
0%
0%
Shareholder Yield
-787.17%
-0.75%
1-Year Price Total Return
-99.97%
-38.36%
Beta (5-Year)
--
0.774
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Technicals

8-day SMA
Buy
Level $9.40
200-day SMA
Sell
Level $173.70
Bollinger Bands (100)
Sell
Level 13.62 - 99.94
Chaikin Money Flow
Sell
Level -25.4M
20-day SMA
Sell
Level $13.60
Relative Strength Index (RSI14)
Sell
Level 39.16
ADX Line
Buy
Level 8.21
Williams %R
Neutral
Level -50.8588
50-day SMA
Sell
Level $23.00
MACD (12, 26)
Sell
Level -4.96
25-day Aroon Oscillator
Sell
Level -72
On Balance Volume
Neutral
Level 159.9M

Financial Scores

Sell
Altman Z-Score (Annual)
Level (-6.2488)
Sell
CA Score (Annual)
Level (-5.2255)
--
Beneish M-Score (Annual)
Level (--)
Sell
Momentum Score
Level (1)
Sell
Ohlson Score
Level (8.4171)
Sell
Piotroski F Score (Annual)
Level (3)
Sell
Quality Ratio Score
Level (1)
Sell
Fundamental Score
Level (2)

Revenue Forecast

Earnings per Share Forecast

Company Profile

Aditxt Inc is a life sciences company that develops, builds, and grows innovations with a focus on monitoring and modulating the immune system. It develops products designed to induce tolerance to transplanted organs. Its portfolio consists of two programs Adimune and AditxtScore. It firm's immunosuppressive (anti-rejection) drugs have made possible life-saving organ transplantation procedures and blocking of unwanted immune responses in autoimmune diseases. It is also developing a technology called Apoptotic DNA Immunotherapy (ADi) ADI-100, which utilizes a novel approach that mimics the way bodies naturally induce tolerance to tissues.

Stock Forecast FAQ

In the current month, ADTX has received 0 Buy ratings 0 Hold ratings, and 0 Sell ratings. The ADTX average analyst price target in the past 3 months is --.

  • Where Will Aditxt Stock Be In 1 Year?

    According to analysts, the consensus estimate is that Aditxt share price will rise to -- per share over the next 12 months.

  • What Do Analysts Say About Aditxt?

    Analysts are divided on their view about Aditxt share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Aditxt is a Sell and believe this share price will drop from its current level to --.

  • What Is Aditxt's Price Target?

    The price target for Aditxt over the next 1-year time period is forecast to be -- according to 0 Wall Street analysts, 0 of them rate the stock a Buy, 0 rate the stock a Sell, and 0 analysts rate the stock a Hold.

  • Is ADTX A Buy, Sell Or Hold?

    According to Wall Street analysts, the consensus rating for Aditxt is a --. 0 of 0 analysts rate the stock a -- at this time.

  • How Can I Buy Shares Of ADTX?

    You can purchase shares of Aditxt via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, tastytrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Aditxt shares.

  • What Is The Aditxt Share Price Today?

    Aditxt was last trading at $10.75 per share. This represents the most recent stock quote for Aditxt. Yesterday, Aditxt closed at $10.69 per share.

  • How To Buy Aditxt Stock Online?

    In order to purchase Aditxt stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is Roblox Stock a Buy, Sell or Hold?
Is Roblox Stock a Buy, Sell or Hold?

Gaming company Roblox (NYSE:RBLX) operates a massive platform that allows…

Is Shopify a Millionaire Maker?
Is Shopify a Millionaire Maker?

Shopify (NYSE:SHOP) is an eCommerce platform, business services provider and…

Is Alphabet Stock No Longer a Good Bet?
Is Alphabet Stock No Longer a Good Bet?

Alphabet tripled its price per share over the past 5…

Stock Ideas

Buy
52
Is AAPL Stock a Buy?

Market Cap: $3.2T
P/E Ratio: 35x

Buy
52
Is NVDA Stock a Buy?

Market Cap: $2.9T
P/E Ratio: 40x

Buy
51
Is MSFT Stock a Buy?

Market Cap: $2.9T
P/E Ratio: 33x

Alerts

Buy
95
EXOD alert for Mar 21

Exodus Movement [EXOD] is up 17.89% over the past day.

Buy
58
SIG alert for Mar 21

Signet Jewelers [SIG] is down 0.64% over the past day.

Sell
43
HQY alert for Mar 21

HealthEquity [HQY] is up 0.28% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock